EURL ECVAM, status report on the development, validation and regulatory acceptance of alternative methods and approaches (2013-April 2014)
The EURL ECVAM status report provides an update on the progress made in the development, validation and regulatory acceptance of alternative methods and approaches since the last report published in April 2013. It is informing on ongoing research and development activities, validation studies, peer reviews, recommendations, strategies and international acceptance of alternative methods and approaches. R&D activities are ongoing for the complex endpoints where the toxicological processes and the mechanistic understanding have not been sufficiently elucidated yet and for which 3Rs solutions... are more difficult to find. On the other hand, good progress In the validation and regulatory acceptance is made in areas where non-animal alternative methods have been developed and validated and where the focus lies in an intelligent combination/ integration of the various non-animal approaches.
- Corporate author(s): Institute for Health and Consumer Protection (Joint Research Centre)
- Personal author(s): Berggren, Elisabet; Desprez, Bertrand; Madia, Federica; Janusch-Roi, Annett; Landesmann, Brigitte; Munn, Sharon; Worth, Andrew; Corvi, Raffaella; Schäffer, Michael; Wittwehr, Clemens; Whelan, Maurice; Coecke, Sandra; Griesinger, Claudius; Price, Anna; Bernasconi, Camilla; Barroso, Joao; Prieto, Pillar; Halder, Marlies; Bessems, Jos; Zuang, Valérie; Casati, Silvia; Milcamps, Anne
- Other authors: EURL ECVAM Themes: Research policy and organisation
- Subject: allergy , carcinogenic substance , consumer protection , cosmetic product , database , eye disease , protection of animals , regulation (EU) , research and development , research method , research report , skin disease , testing , toxic substance , vaccine